Prot #SY-2101-101: An Open-label Phase 1 Study to Evaluate Pharmacokinetics, Safety, and Tolerability of SY-2101 in Adult Patients with Acute Promyelocytic Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date12/16/22 → 12/16/25

Funding

  • Covance Inc. (Prot #SY-2101-101 // Prot #SY-2101-101)
  • Syros Pharmaceuticals, Inc. (Prot #SY-2101-101 // Prot #SY-2101-101)